GILEAD SCIENCES, INC. Short-Term Investments 2008-2026 | GILD
Beta
What is short-term investments?
Short-term investments are marketable securities and other investments that can be readily converted to cash within one year.
What is GILEAD SCIENCES, INC.'s current short-term investments?
GILEAD SCIENCES, INC. (GILD) annual short-term investments for 2025 was $68.0M, a Infinity% increase from 2024. GILEAD SCIENCES, INC. short-term investments for the quarter ending March 31, 2026 was $15.0M.
What was GILEAD SCIENCES, INC.'s short-term investments in 2024?
GILEAD SCIENCES, INC. annual short-term investments for 2024 was $0, a 100.00% decline from 2023.
What was GILEAD SCIENCES, INC.'s short-term investments in 2023?
GILEAD SCIENCES, INC. annual short-term investments for 2023 was $1.18B, a 21.17% increase from 2022.
What is GILEAD SCIENCES, INC.'s 5-year short-term investments CAGR?
GILEAD SCIENCES, INC. short-term investments grew at a compound annual growth rate (CAGR) of 45.47% from FY2020 to FY2025, going from $1.41B to $68.0M over 5 years.
Short-Term Investments History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-45.5%
FY2020
$1.41B
→
FY2025
$68.0M
080910111213141516171819202122232425
5 years selected
Short-Term Investments History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $68.0M | - | 10-K |
| FY2024 | $0 | -100.0% | 10-K |
| FY2023 | $1.18B | +21.2% | 10-K |
| FY2022 | $973.0M | -17.7% | 10-K |
| FY2021 | $1.18B | -16.2% | 10-K |
| FY2020 | $1.41B | -88.9% | 10-K |
| FY2019 | $12.72B | +4.7% | 10-K |
| FY2018 | $12.15B | -32.2% | 10-K |
| FY2017 | $17.92B | +388.9% | 10-K |
| FY2016 | $3.67B | +108.8% | 10-K |
| FY2015 | $1.76B | +1638.6% | 10-K |
| FY2014 | $101.0M | +438.5% | 10-K |
| FY2013 | $18.8M | -68.0% | 10-K |
| FY2012 | $58.6M | +255.1% | 10-K |
| FY2011 | $16.5M | -98.6% | 10-K |
| FY2010 | $1.19B | +210.1% | 10-K |
| FY2009 | $384.0M | +16.1% | 10-K |
| FY2008 | $330.8M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →